{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:41:13Z","timestamp":1762875673696,"version":"3.30.1"},"reference-count":18,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0377-4929.155311","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T07:04:35Z","timestamp":1429254275000},"page":"187","source":"Crossref","is-referenced-by-count":2,"title":["Correlation of JAK2V617F mutational status in primary myelofibrosis with clinico-hematologic characteristics and international prognostic scoring system scoring: A single center experience"],"prefix":"10.4103","volume":"58","author":[{"given":"Renu","family":"Saxena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Sazawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Chhikara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0377-4929.155311-1","first-page":"1779","volume-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0377-4929.155311-2","first-page":"871","volume-title":"Gain of function, loss of control - A molecular basis for chronic myeloproliferative disorders","author":"Cazzola","year":"2005","journal-title":"Haematologica"},{"key":"key-10.4103\/0377-4929.155311-3","first-page":"1092","volume-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel","author":"Tefferi","year":"2007","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.155311-4","first-page":"2162","volume-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.155311-5","first-page":"905","volume-title":"Life expectancy and prognostic factors in the classic BCR\/ABL-negative myeloproliferative disorders","author":"Cervantes","year":"2008","journal-title":"Leukemia"},{"key":"key-10.4103\/0377-4929.155311-6","first-page":"684","volume-title":"Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk groups","author":"Cervantes","year":"1998","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0377-4929.155311-7","first-page":"324","volume-title":"Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: Presenting features, evolution and survival","author":"Cervantes","year":"2001","journal-title":"Eur J Haematol"},{"key":"key-10.4103\/0377-4929.155311-8","first-page":"474","volume-title":"Choosing between stem cell therapy and drugs in myelofibrosis","author":"Kr\u00f6ger","year":"2008","journal-title":"Leukemia"},{"key":"key-10.4103\/0377-4929.155311-9","first-page":"423","volume-title":"Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders","author":"Sazawal","year":"2010","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"key":"key-10.4103\/0377-4929.155311-10","first-page":"1054","volume-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"key-10.4103\/0377-4929.155311-11","first-page":"4030","volume-title":"JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis","author":"Barosi","year":"2007","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.155311-12","first-page":"130","volume-title":"The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more \"erythremic\" and less \"thrombocythemic\": A molecular, histologic, and clinical study","author":"Rudzki","year":"2007","journal-title":"Int J Hematol"},{"key":"key-10.4103\/0377-4929.155311-13","first-page":"385","volume-title":"Correlations between Janus kinase 2 V617F allele burdens and clinicohematologic parameters in myeloproliferative neoplasms","author":"Ha","year":"2012","journal-title":"Ann Lab Med"},{"key":"key-10.4103\/0377-4929.155311-14","first-page":"756","volume-title":"Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"key-10.4103\/0377-4929.155311-15","first-page":"1477","volume-title":"Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele","author":"Guglielmelli","year":"2009","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.155311-16","first-page":"2895","volume-title":"New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment","author":"Cervantes","year":"2009","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.155311-17","first-page":"1723","volume-title":"New mutations and pathogenesis of myeloproliferative neoplasms","author":"Vainchenker","year":"2011","journal-title":"Blood"},{"key":"key-10.4103\/0377-4929.155311-18","first-page":"208","volume-title":"Genetic and epigenetic complexity in myeloproliferative neoplasms","author":"Cross","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T03:55:30Z","timestamp":1429502130000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijpmonline.org\/text.asp?2015\/58\/2\/187\/155311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"alternative-id":["155311"],"URL":"https:\/\/doi.org\/10.4103\/0377-4929.155311","relation":{},"ISSN":["0377-4929"],"issn-type":[{"type":"print","value":"0377-4929"}],"subject":[],"published":{"date-parts":[[2015]]}}}